original ) (raw )β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus , Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
Kieu Tran
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
K. Rodvold
Clinical Infectious Diseases, 2013
View PDFchevron_right
Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains
Kátia Regina Netto Santos
Memórias do Instituto Oswaldo Cruz, 2011
View PDFchevron_right
-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone
Thomas Dilworth
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
Efficacy of vancomycin in combination with various antimicrobial agents against clinical methicillin resistant Staphylococcus aureus strains
GÜLSEREN AKTAŞ
Pakistan Journal of Medical Sciences, 2020
View PDFchevron_right
Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
George Sakoulas
Journal of Clinical Microbiology, 2004
View PDFchevron_right
Synergistic effect of vancomycin combined with cefotaxime, imipenem or meropenem against Staphylocoocus aureus with reduced susceptibility to vancomycin
Sujintana Wongthong
TURKISH JOURNAL OF MEDICAL SCIENCES
View PDFchevron_right
Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Thomas Dilworth
Clinical Therapeutics, 2014
View PDFchevron_right
The role of non-β-lactam antimicrobials and screening for vancomycin resistance in methicillin resistant Staphylococcus aureus
Fatima Khan
Malaysian Journal of Microbiology
View PDFchevron_right
Evaluation of Bactericidal Activities of LY333328, Vancomycin, Teicoplanin, Ampicillin-Sulbactam, Trovafloxacin, and RP59500 Alone or in Combination with Rifampin or Gentamicin against Different Strains of Vancomycin-Intermediate Staphylococcus aureus by Time-Kill Curve Methods
Ellie Hershberger
Antimicrobial Agents and Chemotherapy, 1999
View PDFchevron_right
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovaoxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
Ellie Hershberger
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Vancomycin minimum inhibitory concentrations using different susceptibility methods in Staphylococcus aureus isolates
Thaina Costa
The Journal of Infection in Developing Countries, 2014
View PDFchevron_right
Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus
Ellie Hershberger
Antimicrobial agents and chemotherapy, 1999
View PDFchevron_right
High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients
Hsi-hsun Lin
International Journal of Antimicrobial Agents, 2013
View PDFchevron_right
Evaluation of Vancomycin in Combination with Piperacillin-Tazobactam or Oxacillin against Clinical Methicillin-Resistant Staphylococcus aureus Isolates and Vancomycin-Intermediate S. aureus Isolates In Vitro
Thomas Dilworth
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
David Burgess
Antimicrobial Agents and Chemotherapy, 2020
View PDFchevron_right
Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
James Truong
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Vancomycin resistance in Staphylococcus aureus: a new challenge for infection control and antibiotic prescribing
christine kapesa
Healthcare Infection, 2000
View PDFchevron_right
Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia
Jerome Schentag
Antimicrobial Agents and Chemotherapy, 2007
View PDFchevron_right
Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Jose William Martínez
Clinical Infectious Diseases, 2008
View PDFchevron_right
Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?
balaji veeraraghavan
Infectious Diseases and Therapy, 2018
View PDFchevron_right
Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model
Maria Agudelo , Omar Vesga
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia
Paulina Deming
Journal of Antimicrobial Chemotherapy, 2011
View PDFchevron_right
Vancomycin resistance in Staphylococcus aureus may occur faster than expected
Kiran Babu Tiwari
International Journal of Life Sciences, 2009
View PDFchevron_right
Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin
Tak-keung Ng
Diagnostic Microbiology and Infectious Disease, 2000
View PDFchevron_right
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Dalia Metwally
Clinical Microbiology Reviews, 2010
View PDFchevron_right
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus
Adolf Karchmer
Clinical infectious …, 2009
View PDFchevron_right
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Luis Maldonado
2001
View PDFchevron_right
Study of Vancomycin Resistance Among Staphylococcus Aureus
Agnes Celis
Amadeus International Multidisciplinary Journal
View PDFchevron_right
In Vitro Studies of Pharmacodynamic Properties of Vancomycin against Staphylococcus aureus and Staphylococcus epidermidis
Inga Odenholt
Antimicrobial Agents and Chemotherapy, 1998
View PDFchevron_right
Evaluation of Vancomycin Minimum Inhibitory Concentration in the clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA)
rashmi mahale
Journal of Pure and Applied Microbiology, 2019
View PDFchevron_right